| TAA-Specific CTLS for Solid Tumors (TACTASOM) (NCT02239861) | Baylor College of Medicine | 2015-04-01 |
| Safety Study of GNbAC1 Monoclonal Antibody in Healthy Male Volunteers (NCT02452996) | GeNeuro Innovation SAS | 2015-04-01 |
| First-in-human Study With Ascending Single Intra-articular Doses of GZ389988 in Patients With Painful Osteoarthritis of the Knee (NCT02424942) | Genzyme, a Sanofi Company | 2015-04-01 |
| Pilot Study Using an NMDA Antagonist to Modulate Transcranial Direct Current Stimulation (tDCS) Effects on Sensory Discrimination (NCT02426983) | University of Ottawa | 2015-04-01 |
| An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis Immediately Following a Relapse (NCT02398461) | Acorda Therapeutics | 2015-04-01 |
| Gene-Environment-Interaction: Influence of the COMT Genotype on the Effects of Different Cannabinoids (NCT02487381) | Central Institute of Mental Health, Mannheim | 2015-04-01 |
| Topically Applied IDP-118 Lotion and HP Monad Lotion in Subjects With Moderate to Severe Plaque Psoriasis (NCT03058744) | Bausch Health Americas, Inc. | 2015-04-01 |
| Anti-CD19 Chimeric Antigen Receptor (CAR)-Transduced T Cell Therapy for Patients With B Cell Malignancies (NCT02456350) | Shenzhen Second People's Hospital | 2015-04-01 |
| Patient-Controlled Anxiolysis With Dexmedetomidine (PCA-DEX) for Burn-care Dressing Changes (NCT02409810) | Ohio State University | 2015-04-01 |
| A Study to Compare the Pharmacokinetic Profile of a Proprietary Curcumin Forumulation to a Comparator Curcumin Product (NCT02474953) | KGK Science Inc. | 2015-04-01 |
| A Phase I SAD and MAD Clinical Trial of CNM-Au8 in Healthy Male and Female Volunteers (NCT02755870) | Clene Nanomedicine | 2015-04-01 |
| Cross-over Study to Evaluate the Palatability of New Orally Disintegrating Tablets (ODTs) of Praziquantel (PZQ) and L-PZQ Versus Current PZQ Tablets in African Children Age 6-11 Years (NCT02315352) | Merck KGaA, Darmstadt, Germany | 2015-04-01 |
| Effectiveness of OZ439 as a Gametocytocidal and Transmission Blocking Agent (NCT02431650) | Medicines for Malaria Venture | 2015-04-01 |
| A Phase I Study of Fluzoparib in Patient With Advanced Solid Malignancies (NCT02575651) | Jiangsu HengRui Medicine Co., Ltd. | 2015-04-01 |
| Donor-Alloantigen-Reactive Regulatory T Cell (darTreg) Therapy in Renal Transplantation (The ONE Study ) (NCT02244801) | University of California, San Francisco | 2015-04-01 |
| Study of LEE011plus Cetuximab in Patients With a Cancer of the Head and Neck (NCT02429089) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2015-04-01 |
| A Study of ADXS11-001 or MEDI4736 Alone or Combination In Cervical or Human Papillomavirus (HPV)+ Head & Neck Cancer (NCT02291055) | Advaxis, Inc. | 2015-04-01 |
| Trial of AVB-620 in Women With Primary, Non-Recurrent Breast Cancer Undergoing Surgery (NCT02391194) | Avelas Biosciences, Inc. | 2015-04-01 |
| An Efficacy and Safety Profile of Inhaled TV48108 in Healthy Volunteers and COPD Patients (NCT02315144) | Teva Branded Pharmaceutical Products R&D, Inc. | 2015-04-01 |
| A Study in Healthy Volunteers to Assess the Relative Bioavailability and Tolerability of Two Crenezumab Formulations Following Administration of a Single Subcutaneous Dose (NCT02427243) | Genentech, Inc. | 2015-04-01 |
| Safety of Autologous Human Umbilical Cord Blood Treatment for Perinatal Arterial Ischemic Stroke (NCT02460484) | James Baumgartner, MD | 2015-04-01 |
| Evaluate the Pharmacokinetics and Gonadotropin Suppression of Nestorone®-Testosterone (NES/T) Combination Gel in Men (NCT02432261) | Kimberly Myer | 2015-04-01 |
| Study of Single Doses of IV Aerucin in Healthy Adults (NCT02486770) | Aridis Pharmaceuticals, Inc. | 2015-04-01 |
| A Phase I/II Trial to Evaluate a Peptide Vaccine Plus Ipilimumab in Patients With Melanoma (NCT02385669) | Craig L Slingluff, Jr | 2015-04-01 |
| Investigation of the Safety of Intranasal Glulisine in Down Syndrome (NCT02432716) | HealthPartners Institute | 2015-04-01 |
| Anisodamine Critically Ill SeptIc Shock (NCT02442440) | Jinhua Central Hospital | 2015-04-01 |
| Phase 1/2a Dose-Escalation Study of CRLX301 in Patients With Advanced Solid Tumors (NCT02380677) | NewLink Genetics Corporation | 2015-04-01 |
| GEMHDM2014 : Gem-HDM HDT and ASCT for Relapsed/ Refractory Lymphoma (NCT02295722) | AHS Cancer Control Alberta | 2015-04-01 |
| Safety and Efficacy of UC-MSCs in Patients With Psoriasis Vulgaris (NCT02491658) | Affiliated Hospital to Academy of Military Medical Sciences | 2015-04-01 |
| Exploratory Study of Radium-223 and VEGF-Targeted Therapy in Patients With Metastatic Renal Cell Carcinoma and Bone Mets (NCT02406521) | Dana-Farber Cancer Institute | 2015-04-01 |
| Bioequivalence of a Single Subcutaneous Dose of BEPO and REPO in Healthy Male Subjects (NCT02426151) | LG Life Sciences | 2015-04-01 |
| Fresh Versus Frozen Stool for Fecal Transplant in Children (NCT02423967) | Mayo Clinic | 2015-04-01 |
| A Study to Evaluate the Safety and Immunogenicity of H7N9 Influenza Vaccine (AT-501) in Healthy Adult Subjects (NCT02436928) | Medigen Vaccine Biologics Corp. | 2015-04-01 |
| Study of Pembrolizumab With Chemotherapy in Patients With Advanced Lymphoma (PembroHeme) (NCT02408042) | Western Regional Medical Center | 2015-04-01 |
| A Tissue Collection Study of Pembrolizumab (MK-3475) in Subjects With Resectable Advanced Melanoma (NCT02434354) | Abramson Cancer Center at Penn Medicine | 2015-04-01 |
| Study of Leukocyte Interleukin, Injection for Treatment of Perianal Warts (NCT03038828) | CEL-SCI Corporation | 2015-04-01 |
| PET Imaging Study to Evaluate the mGlu5r Occupancy Following ADX48621 (Dipraglurant) Administration (NCT02447640) | Johns Hopkins University | 2015-04-01 |
| Cell Therapy in Advanced Chronic Obstructive Pulmonary Disease Patients (NCT02412332) | UPECLIN HC FM Botucatu Unesp | 2015-04-01 |
| An Open-label Trial of Intravenous Immune Globulin (IVIG)in Treating Spinocerebellar Ataxias (NCT02287064) | University of South Florida | 2015-04-01 |
| The Effect of Cognitive Enhancement as a Precursor to Computer Based Training for Cognitive Behavioral Therapy (CBT4CBT) (NCT02174614) | Yale University | 2015-04-01 |
| Interleukin-1 Receptor Antagonist for the Treatment of Heart Failure in Patients With Left Ventricular Assist Devices (NCT02547766) | University of Utah | 2015-04-01 |
| Cilostazol-Simvastatin Drug Interaction Study (NCT02431013) | Ajou University School of Medicine | 2015-04-01 |
| Effectiveness and Safety of Adipose-Derived Regenerative Cells for Treatment of Erectile Dysfunction (NCT02472431) | Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation | 2015-04-01 |
| IVIVR Assessing PK Parameters Used to Establish Bioequivalence (NCT02398448) | Ardea Biosciences, Inc. | 2015-04-01 |
| Phase I Dose Escalation Study to Investigate the Safety of ISTH0036 in Subjects With Glaucoma Undergoing Trabeculectomy (NCT02406833) | Isarna Therapeutics GmbH | 2015-04-01 |
| A Study Comparing Clindamycin and Benzoyl Peroxide Gel 1.2%/3.75% to Onexton™ Gel in the Treatment of Acne Vulgaris (NCT02578043) | Sun Pharmaceutical Industries, Inc. | 2015-04-01 |
| A Controlled Study of the Aqueous Humor Dynamics of AR-13324 Ophthalmic Solution in Healthy Adult Volunteers (NCT02406287) | Aerie Pharmaceuticals | 2015-04-01 |
| Allogeneic hMSC Injection in Patients With Hypoplastic Left Heart Syndrome (NCT02398604) | Longeveron Inc. | 2015-04-01 |
| A Clinical Trial to Investigate Safety/Tolerability and Pharmacokinetics of DA-1229_01(Evogliptin/Metformin XR 2.5/500 mg x 2 Tablets) Compared to Co-administration of Evogliptin 5 mg and Metformin XR 1000 mg in Healthy Male Volunteers (NCT02375139) | Dong-A ST Co., Ltd. | 2015-04-01 |
| University of Alabama at Birmingham (UAB) Pediatric CBD Program (NCT02695537) | University of Alabama at Birmingham | 2015-04-01 |
| Communicating Multiple Disease Risks (NCT02621671) | Washington University School of Medicine | 2015-04-01 |
| Evaluating the Combination of MK-3475 and Sterotactic Body Radiotherapy in Patients With Metastatic Melanoma or NSCLC (NCT02407171) | Yale University | 2015-04-01 |
| The Effects of Psilocybin-Facilitated Experience on the Psychology and Effectiveness of Religious Professionals (NCT02421263) | NYU Langone Health | 2015-04-01 |
| Hyperbaric Oxygen, Neutrophil-oxidative Burst, and Cytokines (NCT02563678) | Intermountain Health Care, Inc. | 2015-04-01 |
| CAR-T Hepatic Artery Infusions and Sir-Spheres for Liver Metastases (NCT02416466) | Roger Williams Medical Center | 2015-04-01 |
| Evaluating the Bioequivalence of HIP1403, HGP0919 (NCT02473900) | Hanmi Pharmaceutical Company Limited | 2015-04-01 |
| Multiple Ascending Doses of ZP4207 Administered to HV to Evaluate the Safety, Tolerability, PKs and PDs of ZP4207 (NCT02390141) | Zealand Pharma | 2015-04-01 |
| Safety Study of Inhaled Carbon Monoxide to Treat Acute Respiratory Distress Syndrome (ARDS) (NCT02425579) | Brigham and Women's Hospital | 2015-04-01 |
| Tampostat for Management of Postpartum Hemorrhage (NCT02416089) | International Centre for Diarrhoeal Disease Research, Bangladesh | 2015-04-01 |
| Clinical Trial of Manganese-Enhanced MRI (MEMRI) to Assess Peri-Infarct Injury (NCT02933034) | Stanford University | 2015-04-01 |
| Drug-Drug Interaction Study: ASP2151 and Midazolam (NCT02403635) | Maruho Europe Limited | 2015-04-01 |
| A Study Comparing The Amounts of Tafamidis In The Blood With Or Without Food (NCT02406560) | Pfizer | 2015-04-01 |
| Effect of Lettuce With Different Nitrate Contents on Blood Pressure (NCT02701959) | Newcastle University | 2015-04-01 |
| Persistency Study After aP / Tdap Booster Vaccines in Adult Subjects (V113_01 Extension 1) (NCT02382913) | Novartis | 2015-04-01 |
| Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure (NCT02429557) | Vanderbilt University Medical Center | 2015-04-01 |
| PK and PD of Sequential Multiple Ascending, Repeat Doses of Oral CXA-10 in Healthy Obese Male Subjects (NCT02460146) | Complexa, Inc. | 2015-04-01 |
| Pappalysin 2 (PAPP-A2) Enzyme Replacement (NCT02412943) | Children's Hospital Medical Center, Cincinnati | 2015-04-01 |
| Pharmacokinetic, Safety, Tolerability, and Immunogenicity Study of SB8 in Healthy Male Subjects (NCT02453672) | Samsung Bioepis Co., Ltd. | 2015-04-01 |
| Open Label Study of Single Agent Oral RG7388 in Patients With Polycythemia Vera and Essential Thrombocythemia (NCT02407080) | John Mascarenhas | 2015-04-01 |
| Vitamin D Supplement for Patients With Tibial Fracture (NCT01955577) | Northern Orthopaedic Division, Denmark | 2015-04-01 |
| 68Ga-NODAGA-exendin-4 PET/CT for Diagnostic Imaging in AHH (NCT03189953) | Radboud University Medical Center | 2015-04-01 |
| Fecal Transplantation for Inflammatory Bowel Disease (NCT02391012) | Meir Medical Center | 2015-04-01 |
| Study of Theliatinib (HMPL-309) in Patients With Advanced Solid Tumor (NCT02601274) | Hutchison Medipharma Limited | 2015-04-01 |
| Safety and Efficacy Study of Neovasculgen (Pl-VEGF165) Gene Therapy in Patients With Peripheral Nerve Injury (NCT02352649) | Artgen Biotech | 2015-04-01 |
| Safety and Efficacy Study of OpRegen for Treatment of Advanced Dry-Form Age-Related Macular Degeneration (NCT02286089) | Hoffmann-La Roche | 2015-04-01 |
| Functional Neural Regeneration Collagen Scaffold Transplantation in Acute Spinal Cord Injury Patients (NCT02510365) | Chinese Academy of Sciences | 2015-04-01 |
| Effects of Intranasal Administration of a Single Dose of Oxytocin Using a Novel Device in Adults With Autism Spectrum Disorder (NCT02414503) | OptiNose AS | 2015-04-01 |
| Predictors of Opioid-Induced Respiratory Depression (OIRD) (NCT02473354) | Duke University | 2015-04-01 |
| Role of Sympathetic Activity and Splanchnic Capacitance in Hypertension (NCT02425566) | Vanderbilt University | 2015-04-01 |
| NaF/FDG PET/MRI in Measuring Response to Radium Ra 223 Dichloride in Patients With Metastatic Hormone-Resistant Prostate Cancer (NCT02429804) | Stanford University | 2015-04-01 |
| A Phase 1/2 Study of High-dose Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure (NCT02346422) | Celladon Corporation | 2015-04-01 |
| A Clinical Study to Evaluate PK, PD, and PG of Rosuvastatin in the Elderly (NCT03715101) | Seoul National University Hospital | 2015-04-01 |
| Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - A (NCT02801526) | Chong Kun Dang Pharmaceutical | 2015-04-01 |
| Phase 1 Trial of Inactivated West Nile Virus Vaccine (NCT02337868) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-03-31 |
| A Phase 1b/2 Study of MEDI4736 With Tremelimumab, MEDI4736 or Tremelimumab Monotherapy in Gastric or GEJ Adenocarcinoma (NCT02340975) | MedImmune LLC | 2015-03-31 |
| Study of ORL-1M (D-mannose) in Patients With CDG-Ib (NCT03404869) | Orpha Labs | 2015-03-31 |
| A Phase I/II Study of Ibrutinib in Previously Treated Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NCT02321540) | M.D. Anderson Cancer Center | 2015-03-31 |
| A Study To Describe The Effect Of Impaired Hepatic Function Of The Pharmacokinetics Of Palbociclib (NCT02334800) | Pfizer | 2015-03-31 |
| Molar Potency Study of HM12470 in Healthy Subjects (NCT03330327) | Hanmi Pharmaceutical Company Limited | 2015-03-30 |
| Safety of An Oral O1 / O139 Cholera Vaccine (Enteric Capsules) (NCT03237663) | Jiangsu Province Centers for Disease Control and Prevention | 2015-03-30 |
| Nivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Sarcomas (NCT02304458) | National Cancer Institute (NCI) | 2015-03-30 |
| Evaluate the Pharmacokinetics of Simvastatin When Coadministered With PEX168 in Healthy Adult Subjects (NCT02447601) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2015-03-30 |
| Study of Radiotracer [18F]Fluortriopride ([18F]FTP) by PET/CT (NCT02379338) | University of Pennsylvania | 2015-03-27 |
| VRC 208: Dose, Safety and Immunogenicity of a Recombinant Modified Vaccinia Virus Ankara Ebola Vaccine, VRC-EBOMVA079-00-VP (MVA-EbolaZ), Administered Alone or as a Boost to cAd3-Ebola Vaccines in Healthy Adults (NCT02408913) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-03-26 |
| Safety Study of Enoblituzumab (MGA271) in Combination With Ipilimumab in Refractory Cancer (NCT02381314) | MacroGenics | 2015-03-26 |
| A Safety, Tolerability, and Pharmacokinetics Study of MLN0128 as a Single Agent and in Combination With Paclitaxel in Adults With Advanced Nonhematologic Malignancies (NCT02412722) | Millennium Pharmaceuticals, Inc. | 2015-03-26 |
| Safety and Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine (NCT02405520) | Jun Zhang | 2015-03-26 |
| Evaluation of Hepatic Function Impairment on the Pharmacokinetics of LEE011 (NCT02388620) | Novartis Pharmaceuticals | 2015-03-25 |
| Immune Checkpoint Inhibition (Tremelimumab and/or MEDI4736) in Combination With Radiation Therapy in Patients With Unresectable Pancreatic Cancer (NCT02311361) | National Cancer Institute (NCI) | 2015-03-25 |
| Talazoparib Plus Irinotecan With or Without Temozolomide in Children With Refractory or Recurrent Solid Malignancies (NCT02392793) | St. Jude Children's Research Hospital | 2015-03-25 |